| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.377 | 0.006 | 0.377 | Heat shock protein 90 alpha antagonist | |||
| 0.384 | 0.023 | 0.384 | Peroxidase inhibitor | 0.19 0.062 CID_154699470 | ||
| 0.408 | 0.058 | 0.408 | GABA C receptor rho-3 antagonist | 0.226 0.177 CID_154699470 | ||
| 0.348 | 0.038 | 0.348 | Tumour necrosis factor alpha release inhibitor | |||
| 0.295 | 0.011 | 0.295 | Heat shock protein 90 antagonist | |||
| 0.377 | 0.125 | 0.377 | Caspase 9 stimulant | |||
| 0.238 | 0.017 | 0.238 | ATPase inhibitor | |||
| 0.231 | 0.012 | 0.231 | MAP kinase 3 inhibitor | |||
| 0.268 | 0.052 | 0.268 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.341 | 0.161 | 0.341 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.172 | 0.012 | 0.172 | Transcription factor STAT6 inhibitor | |||
| 0.134 | 0.015 | 0.134 | Phenylalanine 4-hydroxylase inhibitor | 0.078 0.039 CID_154699470 | ||
| 0.148 | 0.031 | 0.148 | GABA C receptor antagonist | 0.108 0.066 CID_154699470 | ||
| 0.164 | 0.051 | 0.164 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.15 | 0.041 | 0.15 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.226 | 0.121 | 0.226 | Insulysin inhibitor | |||
| 0.218 | 0.114 | 0.218 | Transcription factor STAT inhibitor | |||
| 0.226 | 0.122 | 0.226 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.127 | 0.024 | 0.127 | CYP2A6 inhibitor | |||
| 0.109 | 0.007 | 0.109 | Histone deacetylase class II inhibitor | |||
| 0.132 | 0.033 | 0.132 | Sphingomyelinase inhibitor | |||
| 0.185 | 0.088 | 0.185 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.159 | 0.063 | 0.159 | GABA C receptor rho-2 antagonist | |||
| 0.13 | 0.035 | 0.13 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | |||
| 0.102 | 0.012 | 0.102 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.078 0.041 CID_154699470 | ||
| 0.183 | 0.094 | 0.183 | MAP kinase kinase 2 inhibitor | |||
| 0.168 | 0.079 | 0.168 | Tumour necrosis factor antagonist | |||
| 0.095 | 0.01 | 0.095 | Histone deacetylase 5 inhibitor | |||
| 0.183 | 0.098 | 0.183 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.147 | 0.068 | 0.147 | MAP kinase kinase 4 inhibitor | |||
| 0.124 | 0.047 | 0.124 | GABA C receptor agonist | |||
| 0.085 | 0.009 | 0.085 | Histone deacetylase 1 inhibitor | |||
| 0.083 | 0.008 | 0.083 | Glutamate (mGluR4) antagonist | |||
| 0.152 | 0.077 | 0.152 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.083 | 0.008 | 0.083 | Histone deacetylase class IIb inhibitor | |||
| 0.088 | 0.013 | 0.088 | Botulinum neurotoxin type A inhibitor | |||
| 0.082 | 0.008 | 0.082 | Histone deacetylase 6 inhibitor | |||
| 0.095 | 0.024 | 0.095 | Raf kinase B inhibitor | |||
| 0.077 | 0.007 | 0.077 | Immunoglobulin Fc receptor antagonist | |||
| 0.101 | 0.032 | 0.101 | mTOR complex 2 inhibitor | |||
| 0.169 | 0.101 | 0.169 | Focal adhesion kinase 2 inhibitor | |||
| 0.131 | 0.064 | 0.131 | MAP kinase kinase inhibitor | |||
| 0.099 | 0.033 | 0.099 | Raf kinase inhibitor | |||
| 0.074 | 0.01 | 0.074 | Histone deacetylase class IIa inhibitor | |||
| 0.166 | 0.103 | 0.166 | I kappa B kinase epsilon inhibitor | |||
| 0.129 | 0.068 | 0.129 | Cyclin-dependent kinase inhibitor | |||
| 0.19 | 0.129 | 0.389 | Superoxide dismutase inhibitor | 0.389 0.029 CID_154699470 | CID_154699470 | |
| 0.172 | 0.112 | 0.172 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.111 | 0.055 | 0.111 | 5-Lipoxygenase inhibitor | |||
| 0.111 | 0.056 | 0.111 | CDC-like kinase 3 inhibitor | |||
| 0.067 | 0.012 | 0.067 | Histone deacetylase 2 inhibitor | |||
| 0.112 | 0.06 | 0.112 | Ferrochelatase inhibitor | |||
| 0.1 | 0.048 | 0.134 | Triose-phosphate isomerase inhibitor | 0.134 0.025 CID_154699470 | CID_154699470 | |
| 0.133 | 0.082 | 0.133 | Activin receptor-like kinase 2 inhibitor | |||
| 0.123 | 0.077 | 0.123 | Cyclooxygenase 1 inhibitor | |||
| 0.178 | 0.133 | 0.178 | Nitric-oxide synthase stimulant | |||
| 0.146 | 0.102 | 0.146 | LIM domain kinase 1 inhibitor | |||
| 0.116 | 0.072 | 0.116 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.06 | 0.017 | 0.06 | Cyclin D3 inhibitor | |||
| 0.116 | 0.072 | 0.116 | Abl kinase inhibitor | |||
| 0.102 | 0.059 | 0.102 | UDP-glucose 4-epimerase inhibitor | |||
| 0.057 | 0.015 | 0.057 | Glutamate (mGluR group III) antagonist | |||
| 0.058 | 0.019 | 0.058 | Thymidylate synthase inhibitor | |||
| 0.051 | 0.012 | 0.051 | Histone deacetylase 4 inhibitor | |||
| 0.051 | 0.013 | 0.051 | Histone deacetylase 11 inhibitor | |||
| 0.051 | 0.013 | 0.051 | Histone deacetylase class IV inhibitor | |||
| 0.049 | 0.012 | 0.049 | Histone deacetylase 10 inhibitor | |||
| 0.162 | 0.125 | 0.162 | Dyrk kinase inhibitor | |||
| 0.099 | 0.063 | 0.099 | GABA C receptor rho-1 antagonist | |||
| 0.05 | 0.016 | 0.05 | Alpha 1d adrenoreceptor agonist | |||
| 0.086 | 0.054 | 0.086 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.189 | 0.158 | 0.189 | MAP kinase kinase 3 inhibitor | |||
| 0.114 | 0.084 | 0.114 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.16 | 0.13 | 0.16 | Aldehyde oxidase inhibitor | |||
| 0.043 | 0.013 | 0.043 | ADAM10 endopeptidase inhibitor | |||
| 0.174 | 0.144 | 0.262 | RNA-directed DNA polymerase inhibitor | 0.262 0.043 CID_154699470 | CID_154699470 | |
| 0.125 | 0.096 | 0.125 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.063 | 0.037 | 0.063 | Aminopeptidase microsomal inhibitor | |||
| 0.049 | 0.023 | 0.049 | Geranyltranstransferase inhibitor | |||
| 0.053 | 0.027 | 0.053 | Adenosine deaminase inhibitor | |||
| 0.086 | 0.06 | 0.086 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.097 | 0.072 | 0.097 | Adenylate kinase inhibitor | 0.097 0.072 CID_154699470 | ||
| 0.037 | 0.013 | 0.037 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.08 | 0.057 | 0.08 | Platelet growth factor antagonist | |||
| 0.093 | 0.07 | 0.127 | Aminopeptidase B inhibitor | 0.127 0.049 CID_154699470 | CID_154699470 | |
| 0.095 | 0.073 | 0.095 | mTOR complex 1 inhibitor | |||
| 0.073 | 0.051 | 0.073 | Glutamate decarboxylase inhibitor | |||
| 0.058 | 0.036 | 0.058 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.214 | 0.193 | 0.214 | Calcium channel activator | |||
| 0.05 | 0.03 | 0.05 | Cytokine production stimulant | |||
| 0.116 | 0.097 | 0.116 | Protein kinase stimulant | |||
| 0.142 | 0.123 | 0.142 | Pyruvate kinase inhibitor | |||
| 0.143 | 0.124 | 0.143 | Death-associated protein kinase 2 inhibitor | |||
| 0.122 | 0.104 | 0.122 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.064 | 0.047 | 0.064 | Histone deacetylase inhibitor | |||
| 0.067 | 0.05 | 0.067 | Exportin-1 inhibitor | |||
| 0.031 | 0.014 | 0.031 | Histone deacetylase 3 inhibitor | |||
| 0.074 | 0.057 | 0.074 | GABA B receptor agonist | |||
| 0.055 | 0.039 | 0.055 | Dihydroorotate oxidase inhibitor | |||
| 0.019 | 0.004 | 0.019 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.048 | 0.033 | 0.048 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.035 | 0.021 | 0.035 | CDK6/cyclin D3 inhibitor | |||
| 0.131 | 0.117 | 0.131 | Ca2+-transporting ATPase inhibitor | |||
| 0.049 | 0.035 | 0.049 | Phosphatidylinositol 3-kinase beta inhibitor | |||
| 0.063 | 0.052 | 0.063 | MAP kinase kinase 10 inhibitor | |||
| 0.029 | 0.019 | 0.029 | Purinergic P2Y15 antagonist | |||
| 0.045 | 0.036 | 0.045 | Aminopeptidase N inhibitor | |||
| 0.048 | 0.041 | 0.048 | Aconitate hydratase inhibitor | |||
| 0.078 | 0.071 | 0.078 | Myeloperoxidase inhibitor | |||
| 0.027 | 0.022 | 0.027 | CDK4/cyclin D3 inhibitor | |||
| 0.027 | 0.022 | 0.027 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.008 | 0.004 | 0.008 | CC chemokine 6 receptor agonist | |||
| 0.036 | 0.032 | 0.036 | Vascular adhesion protein 1 inhibitor | |||
| 0.041 | 0.038 | 0.041 | Histamine H1 receptor agonist | |||
| 0.058 | 0.057 | 0.058 | Aryl hydrocarbon receptor antagonist | |||
| 0.138 | 0.137 | 0.138 | Succinate dehydrogenase inhibitor | |||
| 0.078 | 0.093 | 0.133 | Protein kinase C zeta inhibitor | 0.133 0.026 CID_154699470 | CID_154699470 | |
| 0.109 | 0.154 | 0.124 | Adenylate cyclase stimulant | 0.124 0.116 CID_154699470 | CID_154699470 | |
| 0.01 | 0.073 | 0.03 | Glutamate (mGluR1a) agonist | 0.03 0.009 CID_154699470 | CID_154699470 | |
| 0.054 | 0.129 | 0.078 | Inducible nitric-oxide synthase inhibitor | 0.078 0.065 CID_154699470 | CID_154699470 | |
| 0.028 | 0.12 | 0.055 | Alpha-mannosidase inhibitor | 0.055 0.035 CID_154699470 | CID_154699470 | |
| 0.02 | 0.112 | 0.045 | Mannosidase inhibitor | 0.045 0.032 CID_154699470 | CID_154699470 | |
| 0.071 | 0.184 | 0.113 | Acetylcholine release stimulant | 0.113 0.06 CID_154699470 | CID_154699470 | |
| 0.087 | 0.219 | 0.16 | Hemostatic | 0.16 0.057 CID_154699470 | CID_154699470 | |
| 0.14 | 0.308 | 0.214 | Histamine release inhibitor | 0.214 0.186 CID_154699470 | CID_154699470 | |
| 0.024 | 0.203 | 0.05 | Heparanase inhibitor | 0.05 0.045 CID_154699470 | CID_154699470 | |
| 0.06 | 0.276 | 0.148 | Cell wall synthesis inhibitor | 0.148 0.067 CID_154699470 | CID_154699470 | |
| 0.092 | 0.351 | 0.229 | Angiogenesis inhibitor | 0.229 0.139 CID_154699470 | CID_154699470 | |
| 0.109 | 0.377 | 0.317 | Antibacterial | 0.317 0.123 CID_154699470 | CID_154699470 | |
| 0.086 | 0.377 | 0.189 | Cholesterol antagonist | 0.189 0.175 CID_154699470 | CID_154699470 | |
| 0.092 | 0.417 | 0.236 | Sodium/bile acid cotransporter inhibitor | 0.236 0.144 CID_154699470 | CID_154699470 | |
| 0.034 | 0.4 | 0.241 | Anticoagulant | 0.241 0.041 CID_154699470 | CID_154699470 | |
| 0.019 | 0.389 | 0.095 | Factor IXa inhibitor | 0.095 0.011 CID_154699470 | CID_154699470 | |
| 0.011 | 0.41 | 0.042 | Purinergic P2Y2 antagonist | 0.042 0.014 CID_154699470 | CID_154699470 | |
| 0.005 | 0.516 | 0.194 | NMDA 2B receptor antagonist | 0.194 0.006 CID_154699470 | CID_154699470 | |
| 0.077 | 0.593 | 0.259 | Antiinflammatory | 0.259 0.257 CID_154699470 | CID_154699470 | |
| 0.005 | 0.564 | 0.044 | NMDA 2D receptor antagonist | 0.044 0.009 CID_154699470 | CID_154699470 | |
| 0.003 | 0.599 | 0.165 | Cholecystokinin A agonist | 0.165 0.003 CID_154699470 | CID_154699470 | |
| 0.008 | 0.623 | 0.194 | Diuretic | 0.194 0.046 CID_154699470 | CID_154699470 | |
| 0.005 | 0.637 | 0.051 | HIV-1 integrase (Strand Transfer) inhibitor | 0.051 0.049 CID_154699470 | CID_154699470 | |
| 0.003 | 0.643 | 0.188 | Cholecystokinin agonist | 0.188 0.003 CID_154699470 | CID_154699470 | |
| 0.005 | 0.66 | 0.094 | Selectin antagonist | 0.094 0.03 CID_154699470 | CID_154699470 | |
| 0.008 | 0.687 | 0.353 | Cholecystokinin B agonist | 0.353 0.003 CID_154699470 | CID_154699470 | |
| 0.009 | 0.791 | 0.11 | Multidrug resistance-associated protein 1 inhibitor | 0.11 0.062 CID_154699470 | CID_154699470 | |
| 0.005 | 0.812 | 0.117 | CDC25A inhibitor | 0.117 0.02 CID_154699470 | CID_154699470 | |
| 0.003 | 0.816 | 0.069 | Cholecystokinin A antagonist | 0.069 0.015 CID_154699470 | CID_154699470 | |
| 0.003 | 0.854 | 0.039 | Cholecystokinin antagonist | 0.039 0.03 CID_154699470 | CID_154699470 | |
| 0.008 | 0.894 | 0.29 | Angiogenesis stimulant | 0.29 0.053 CID_154699470 | CID_154699470 | |
| 0.006 | 0.918 | 0.342 | Cyclophilin D inhibitor | 0.342 0.128 CID_154699470 | CID_154699470 | |
| 0.004 | 0.958 | 0.264 | Dual specificity phosphatase 3 inhibitor | 0.264 0.036 CID_154699470 | CID_154699470 | |
| 0.004 | 0.978 | 0.239 | Dual specificity phosphatase inhibitor | 0.239 0.04 CID_154699470 | CID_154699470 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |